The FDA has approved Wegovy HD, a higherdose formulation of Novo Nordisks Wegovy (semaglutide), marking the fourth product cleared under its Commissioners National Priority Voucher (CNPV) pilot program, which is an accelerated review pathway designed to shorten review timelines for therapies aligned with national health priorities
Patients usually experience: Sudden, painless vision loss in one eye that occurs upon waking up or is noticed within the first few hours of the day One-sided involvement, with one eye being affected initially, although theres an increased risk for the other eye Specific visual field defects, most commonly affecting the lower part of the visual field Swelling of the optic disc and visible bleeding during an eye examination A relative defect in pupil response in the affected eye NAION Symptoms and Causes The Absence of Pain: The typical NAION symptoms appear suddenly without any warning signs beforehand

Our treatments are often combined with: Vitamin C infusions for antioxidant synergy NAD+ therapy to enhance energy and repair Red light therapy (Photobiomodulation) for skin rejuvenation Morpheus8 or laser resurfacing for collagen stimulation By integrating internal and external treatments, we help our patients achieve long-lasting, natural-looking results that enhance both skin appearance and overall wellbeing
Why Physician Supervision Matters A prescription is only the beginning
Compounded products are not identical to brand and are priced separately, on their own published structure rather than as a discount off any list price
Semaglutide and Dulaglutide offer the closest half-life profiles for comparative studies